A Randomized, Double-Blinded, Placebo-Controlled Study of Sorafenib in Patients With Advanced Hepatocellular Carcinoma

This study has been completed.

Study NCT00492752 Information provided by Bayer

First Received: June 26, 2007 Last Updated: August 20, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Study Completion Date:	June 2009
Primary Completion Date:	March 2007 (Final data collection date for primary outcome measure)